ArticleJournal of diabetes and metabolic disorders2025
Combined effects of sodium alginate supplementation with HIIT and MICT on CCK and PYY levels in men with metabolic syndrome.
Article in Journal of diabetes and metabolic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Abdominal obesity is a prevalent characteristic of individuals with Metabolic Syndrome (MetS). Effective weight management strategies that induce satiety play a crucial role in reducing the risk of obesity and, consequently, MetS. This study aimed to investigate the impact of sodium alginate supplementation in conjunction with High-Intensity Interval Training (HIIT) and Moderate-Intensity Continuous Training (MICT) on the increment of Cholecystokinin (CCK) and Peptide YY (PYY) levels in men with MetS. Methods: Forty men with MetS volunteered for this study and were randomly assigned to one of five groups: HIIT (high-intensity interval training), HIIT + S (high-intensity interval training + sodium alginate supplementation), MICT (moderate-intensity interval training), MICT + S (moderate-intensity interval training + sodium alginate supplementation), and control (C), which received no intervention. The HIIT groups performed four bouts of four minutes at 85-95% of their Peak Heart Rate (HR peak), with three minutes of active recovery at 50-70% HR peak, three sessions per week. The MICT groups engaged in 30 min of exercise at 60-70% HR peak, three sessions per week. The HIIT + S and MICT + S groups consumed 1.5 g of Sigma sodium alginate solution (manufactured in the USA) dissolved in 100 mg of sweet water (containing 7 g of fructose) 30 min before their three main meals, three days per week, for eight weeks. Results: After eight weeks of interventions, CCK and PYY levels significantly increased in all studied groups. The HIIT + S group exhibited a significantly greater increase compared to the other groups. Additionally, the MetS Z score significantly decreased in all studied groups, with the HIIT + S group demonstrating a significantly greater decrease compared to the other groups ( Conclusion: The findings of this study indicate that both HIIT and MICT contribute to overall improvement in men with MetS. However, the combination of sodium alginate supplementation with exercise further enhances these improvements. These findings support integrating sodium alginate and exercise into MetS management to enhance satiety and improve metabolic profiles. Limitations include the short duration (8 weeks) and small sample size, which limit long-term conclusions. Trial registration: The trial, with the reference number IR.KUMS.REC.1398.214, underwent approval by the Research Ethics Committees of Kermanshah University of Medical Sciences. The trial was subsequently registered in the Iranian Clinical Trial Registration Center under the code IRCT20190916044788N1 on 03/12/2020.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.